Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxorubicin-associated Cardiac Tissue Remodeling Followed by CMR of Myocardial Extracellular Volume and Myocyte Size in Breast Cancer Patients

NCT03000036 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT03000036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03000036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxorubicin-associated Cardiac Tissue Remodeling Followed by CMR of Myocardial Extracellular Volume and Myocyte Size in Breast Cancer Patients
Lead sponsor
University of Campinas, Brazil
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
July 31, 2016
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, doxorubicin induced cardiomyopathy